The evolving need for patient reported outcome data in determining choice of immune therapy treatment

Jennifer Saultz; Richard T. Maziarz

doi:10.1016/j.medj.2021.07.002

The evolving need for patient reported outcome data in determining choice of immune therapy treatment

Research output: Contribution to journal › Article › peer-review

Abstract

Cellular therapy has changed the cancer treatment landscape and potential associated toxicities. The traditional short-term toxicities of chemotherapy-induced nausea, vomiting, and diarrhea are replaced by complex immune activation syndromes and immunologic organ-specific toxicities. Understanding the long-term consequences and impact of these therapies on patient quality of life is necessary.

Original language	English (US)
Pages (from-to)	907-911
Number of pages	5
Journal	Med
Volume	2
Issue number	8
DOIs	https://doi.org/10.1016/j.medj.2021.07.002
State	Published - Aug 13 2021

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.medj.2021.07.002

Cite this

@article{6910407f0736476eaef184be8d775a66,

title = "The evolving need for patient reported outcome data in determining choice of immune therapy treatment",

abstract = "Cellular therapy has changed the cancer treatment landscape and potential associated toxicities. The traditional short-term toxicities of chemotherapy-induced nausea, vomiting, and diarrhea are replaced by complex immune activation syndromes and immunologic organ-specific toxicities. Understanding the long-term consequences and impact of these therapies on patient quality of life is necessary.",

author = "Jennifer Saultz and Maziarz, {Richard T.}",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",

year = "2021",

month = aug,

day = "13",

doi = "10.1016/j.medj.2021.07.002",

language = "English (US)",

volume = "2",

pages = "907--911",

journal = "Med",

issn = "2666-6359",

publisher = "Cell Press",

number = "8",

}

TY - JOUR

T1 - The evolving need for patient reported outcome data in determining choice of immune therapy treatment

AU - Saultz, Jennifer

AU - Maziarz, Richard T.

PY - 2021/8/13

Y1 - 2021/8/13

N2 - Cellular therapy has changed the cancer treatment landscape and potential associated toxicities. The traditional short-term toxicities of chemotherapy-induced nausea, vomiting, and diarrhea are replaced by complex immune activation syndromes and immunologic organ-specific toxicities. Understanding the long-term consequences and impact of these therapies on patient quality of life is necessary.

AB - Cellular therapy has changed the cancer treatment landscape and potential associated toxicities. The traditional short-term toxicities of chemotherapy-induced nausea, vomiting, and diarrhea are replaced by complex immune activation syndromes and immunologic organ-specific toxicities. Understanding the long-term consequences and impact of these therapies on patient quality of life is necessary.

UR - http://www.scopus.com/inward/record.url?scp=85123012971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123012971&partnerID=8YFLogxK

U2 - 10.1016/j.medj.2021.07.002

DO - 10.1016/j.medj.2021.07.002

M3 - Article

C2 - 35590167

AN - SCOPUS:85123012971

SN - 2666-6359

VL - 2

SP - 907

EP - 911

JO - Med

JF - Med

IS - 8

ER -

The evolving need for patient reported outcome data in determining choice of immune therapy treatment

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this